Resan Mirko, Vukosavljević Miroslav, Milivojević Milorad
Klinika za ocne bolesti, Vojnomedicinska akademija, Beograd, Srbija.
Vojnosanit Pregl. 2012 Oct;69(10):852-7. doi: 10.2298/vsp1210852r.
BACKGROUND/AIM: Photorefractive keratectomy (PRK), after laser in situ keratomileusis (LASIK), is commonly performed refractive surgical method worldwide. The aim of this study was to examine the effectiveness and safety of PRK in correction of various strengths of myopia and to assess how much corneal tissue is being removed with one diopter sphere (Dsph) correction by using different optical zones (OZ).
A prospective study with a follow-up period of 6 months included 55 patients of which 100 myopic eyes were treated by PRIK method (one eye was included in 10 patients). Myopic eyes with a preoperative best corrected visual acuity (BCVA) = 1.0 (20/20) were analysed. In order to assess the effectiveness of PRK operated myopic eyes were divided into four groups according to the dioptric power: (1) < or = -1.75 Dsph (n=26); 2) from -2 to -3.75 Dsph (n=44); 3) from -4 to -6.75 Dsph (n=23), and 4) > or = -7 Dsph (n=7). Myopic eyes with preoperative BCVA < or = 0.9 (amblyopic eyes) were excluded from the study, as well as eyes with astigmatism > -1.5 Dcyl. To assess the effectiveness of PRK we examined the percentage of eyes in the mentioned groups, which derived uncorrected visual acuity (UCVA) 6 months after the intervention to the following: (a) UCVA = 1.0 (20/20) and (b) UCVA > or = 0.5 (20/40). To assess the safety of PRK we examined the frequency of intraoperative and postoperative complications. To estimate how much corneal tissue was removed with one Dsph correction by using different OZ, we used preoperative and postoperative (after 6 months) central pachymetry values expressed in microm and volume of cornea (central 7 mm) expressed in mm3. In that sense, we used only the myopic eyes with clear preoperative spherical refraction. The total number of these eyes was 27, of which 16 eyes were treated using a 6.5 mm OZ and 11 eyes using a 7 mm OZ.
Refractive spherical equivalent (RSE) for all eyes was in the range from -0.75 to -8.75 Dsph, and preoperative mean value of RSE with standard deviation (mean RSE +/- SD) was -3.32 +/- 1.83 Dsph. Six months after PRK, 91% of eyes had UCVA = 20/20, and 99% of eyes had UCVA > or = 20/40. In the first group (< or = -1.75 Dsph) preoperative mean RSE +/- SD was -1.34 +/- 0.32 Dsph, six months after PRK, 96% of eyes had UCVA = 20/20, and 100% of eyes had UCVA > or = 20/40. In the second group (from -2 to -3.75 Dsph) preoperative mean RSE +/- SD was - 2.95 +/- 0.57 Dsph, six months after PRK, 89% of eyes had UCVA = 20/20, and 100% of eyes had UCVA > or = 20/40. In the third group (from -4 to -6.75 Dsph) preoperative mean RSE +/- SD was -4.93 +/- 0.70 Dsph, six months after PRK, 100% of eyes had UCVA = 20/20. In the fourth group (> or = -7 Dsph) preoperative mean RSE +/- SD was -7.71 +/- 0.67 Dsph, six months after PRK, 57% of eyes had UCVA = 20/20, and 86% of eyes had UCVA > or = 20/40. There were no intraoperative complications while postoperative complications occurred in 2 patients - in both cases in one eye (2%). In that cases, epithelial defects were detected. In the group of eyes that were treated by 6.5 mm OZ mean RSE +/- SD was -2.45 +/- 0.99 Dsph, the ablation depth per 1 Dsph was 17.54 +/- 5.58 microm and ablated volume of central 7 mm cornea by 1 Dsph was 0.43 +/- 0.18 mm3. In the group of eyes that were treated by 7 mm OZ mean RSE +/- SD was -3.32 +/- 2.26 Dsph, the ablation depth per 1 Dsph was 23.73 +/- 6.91 microm and ablated volume of central 7 mm cornea by 1 Dsph was 0.61 +/- 0.31 mm3.
PRK is effective and safe refractive surgical method for correcting myopia up to -8.75 Dsph. OZ size is the main factor determining the depth of the excimer laser ablation of the corneal tissue volume consumed by 1 Dsph. Higher OZ value determines higher consumption of cornea tissue.
背景/目的:准分子原位角膜磨镶术(LASIK)后进行的准分子激光角膜切削术(PRK)是全球常用的屈光手术方法。本研究的目的是检验PRK矫正不同度数近视的有效性和安全性,并评估使用不同光学区(OZ)矫正1个屈光度球镜(Dsph)时角膜组织的切除量。
一项随访期为6个月的前瞻性研究纳入了55例患者,共100只近视眼睛接受PRK治疗(10例患者中1例为双眼)。分析术前最佳矫正视力(BCVA)=1.0(20/20)的近视眼睛。为评估PRK治疗近视眼睛的有效性,根据屈光度将其分为四组:(1)≤-1.75 Dsph(n = 26);2)-2至-3.75 Dsph(n = 44);3)-4至-6.75 Dsph(n = 23);4)≥-7 Dsph(n = 7)。术前BCVA≤0.9的近视眼睛(弱视眼)以及散光>-1.5 Dcyl的眼睛被排除在研究之外。为评估PRK的有效性,我们检查了上述组中干预6个月后裸眼视力(UCVA)达到以下情况的眼睛百分比:(a)UCVA = 1.0(20/20)和(b)UCVA≥0.5(20/40)。为评估PRK的安全性,我们检查了术中及术后并发症的发生率。为估计使用不同OZ矫正1个Dsph时切除的角膜组织量,我们使用术前和术后(6个月后)以微米表示的中央角膜厚度值以及以mm³表示的角膜(中央7 mm)体积。从这个意义上讲,我们仅使用术前球镜屈光清晰的近视眼睛。这些眼睛的总数为27只,其中16只眼睛使用6.5 mm OZ进行治疗,11只眼睛使用7 mm OZ进行治疗。
所有眼睛的屈光球镜等效值(RSE)范围为-0.75至-8.75 Dsph,术前RSE的平均值及标准差(平均RSE±SD)为-3.32±1.83 Dsph。PRK术后6个月,91%的眼睛UCVA = 20/20,99%的眼睛UCVA≥20/40。第一组(≤-1.75 Dsph)术前平均RSE±SD为-1.34±0.32 Dsph,PRK术后6个月,96%的眼睛UCVA = 20/